Étanercept = EtanerceptDESCAMPS, V.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 845-847, issn 0151-9638, 3 p.Article

AdalimumabAUBIN, F; BARTHELEMY, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 842-844, issn 0151-9638, 3 p.Article

Update on Alefacept SafetyWEXLER, Denise; SEARLES, Gordon; LANDELLS, Ian et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, issn 1203-4754, S139-S147, SUP3Article

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patientsJAMNITSKI, A; KRIECKAERT, C. L; NURMOHAMED, M. T et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 1, pp 88-91, issn 0003-4967, 4 p.Article

Cumulative Irritation Potential and Contact Sensitization Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch StudiesBERG, Jeffrey E; BOWMAN, James P; ALIO SAENZ, Alessandra B et al.Cutis (New York, NY). 2012, Vol 90, Num 4, pp 206-211, issn 0011-4162, 6 p.Article

Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tarARBISER, Jack L; GOVINDARAJAN, Baskaran; KLEIN, Eva et al.Journal of investigative dermatology. 2006, Vol 126, Num 6, pp 1396-1402, issn 0022-202X, 7 p.Article

Systemic antipsoriatic therapy may reverse endothelial dysfunction: reply from authorsMARTYN-SIMMONS, C. L; SMITH, C. H; BARKER, J. N. W. N et al.British journal of dermatology (1951). 2011, Vol 164, Num 6, issn 0007-0963, p. 1398Article

Dimethylfumarate Inhibits Angiogenesis In vitro and In vivo: A Possible Role for Its Antipsoriatic Effect?GARCIA-CABALLERO, Melissa; MARI-BEFFA, Manuel; MEDINA, Miguel A et al.Journal of investigative dermatology. 2011, Vol 131, Num 6, pp 1347-1355, issn 0022-202X, 9 p.Article

T-cell clone associated with efalizumab therapyLYNCH, M; MURPHY, K; SLABY, J et al.Clinical and experimental dermatology (Print). 2011, Vol 36, Num 1, pp 99-100, issn 0307-6938, 2 p.Article

Lettre d'information pour le traitement du psoriasis par l'adalimumab (Humira^®) = Information letter on treatment of psoriasis with adalimumab (Humira^®)Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 868-870, issn 0151-9638, 3 p.Article

Frequency and Effectiveness of Dose Increase of Adalimumab, Etanercept, and Infliximab in Daily Clinical PracticeBLOM, M; KIEVIT, W; KUPER, H. H et al.Arthritis care and research. 2010, Vol 62, Num 9, pp 1335-1341, issn 0893-7524, 7 p.Article

Adalimumab : In Plaque PsoriasisCROOM, Katherine F; MCCORMACK, Paul L.American journal of clinical dermatology. 2009, Vol 10, Num 1, pp 43-50, issn 1175-0561, 8 p.Article

Alefacept revisited : Our 3-year clinical experience in 200 patients with chronic plaque psoriasisPERLMUTTER, Amy; CATHER, Jennifer; FRANKS, Billy et al.Journal of the American Academy of Dermatology. 2008, Vol 58, Num 1, pp 116-124, issn 0190-9622, 9 p.Article

Paraqueratosis granular = Granular parakeratosisGONZALEZ DE ARRIBA, M; VALLES-BLANCO, L; POLO-RODRIGUEZ, I et al.Actas dermo-sifiliográficas (Ed. impresa). 2007, Vol 98, Num 5, pp 355-357, issn 0001-7310, 3 p.Article

Conseils aux patients ayant un psoriasis et utilisant le Soriatane : Psoriasis = Recommandations in psoriasis treated by SoriataneLa Revue du praticien (Paris). 2004, Vol 54, Num 1, issn 0035-2640, p. 70Article

The efficacy of alefacept in the treatment of chronic plaque psoriasisGORDON, Kenneth B; VALENTINE, Jayme.Journal of cutaneous medicine and surgery. 2004, Vol 8, pp 3-9, issn 1203-4754, 7 p., SUP2Article

Alefacept is well tolerated in patients with chronic plaque psoriasisGOTTLIEB, Alice B.Journal of cutaneous medicine and surgery. 2004, Vol 8, pp 14-19, issn 1203-4754, 6 p., SUP2Article

Long-term outcome of severe chronic plaque psoriasis following treatment with high-dose topical calcipotriolBLEIKER, T. O; BOURKE, J. F; MUMFORD, R et al.British journal of dermatology (1951). 1998, Vol 139, Num 2, pp 285-286, issn 0007-0963Article

Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanerceptVAN LUIJN, J. C. F; DANZ, M; BIJISMA, J. W. J et al.Scandinavian journal of rheumatology. 2011, Vol 40, Num 3, pp 183-191, issn 0300-9742, 9 p.Article

Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanerceptFIELD, S; REGAN, A. O; SHEAHAN, K et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 7, pp 795-796, issn 0307-6938, 2 p.Article

Neoral in Psoriasis. RoundtableMILLIKAN, L.International journal of dermatology. 1997, Vol 36, issn 0011-9059, 46 p., SUP1Conference Proceedings

Etanercept-induced lichen planus-like eruptions following the lines of BlaschkoUTSU, Momoko; HIDA, Tokimasa; TAKAHASHI, Hiroki et al.EJD. European journal of dermatology. 2012, Vol 22, Num 4, pp 544-545, issn 1167-1122, 2 p.Article

Long-term efficacy of etanercept for psoriasis in daily practiceVAN LÜMIG, P. P. M; DRIESSEN, R. J. B; BOEZEMAN, J. B. M et al.British journal of dermatology (1951). 2012, Vol 166, Num 2, pp 445-447, issn 0007-0963, 3 p.Article

Etanercept: An Overview of Dermatologic Adverse EventsLECLUSE, Lidian L. A; DOWLATSHAHI, Emmilia A; JACQUELINE, C. E et al.Archives of dermatology (1960). 2011, Vol 147, Num 1, pp 79-94, issn 0003-987X, 16 p.Article

Photoleukomelanoderma Possibly Caused by Etretinate in a Patient with PsoriasisSEISHIMA, Mariko; SHIBUYA, Yoshinao; KATO, Genichi et al.Acta dermato-venereologica. 2010, Vol 90, Num 1, pp 85-86, issn 0001-5555, 2 p.Article